Clinical trial
A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the…
NCT00436033 · Pierre Fabre Medicament, Industry · Completed
Key facts
| NCT number | NCT00436033 |
|---|---|
| Title | A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome |
| Official title | A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome |
| Lead sponsor | Pierre Fabre Medicament, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fibromyalgia Syndrome |
| Intervention type | Drug |
| Interventions | milnacipran, Placebo |
| Enrollment | 1,429 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Feb 16, 2007 |
| Last update posted | Jul 11, 2013 |
| Countries | Czechia, Denmark, Finland, France, Germany, Italy, Norway, Poland, Portugal, Romania, Spain, Sweden and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: